FindTrial
Sign In

Comparison of inj. Dexmedetomedine and magnesium sulphate in spinal Anaesthesia to prevent Shivering in LSCS.

Comparison of Intrathecal Dexmedetomedine and Intrathecal Magnesium Sulfate for the Prevention of Post-spinal Anaesthesia Shivering in Lower Segment Caesarean Section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049601
Enrollment
150
Registered
2023-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O94-O9A- Other obstetric conditions, not elsewhere classified

Interventions

Intervention1: Post spinal Anaesthesia Shivering: Comparison of Intrathecal Dexmedetomedine and Intrathecal Magnesium Sulfate Intervention2: Post spinal Anaesthesia Shivering: Comparison of Intratheca

Sponsors

Department of Anaesthesiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 to 45 years ASA physical status I-II. Scheduled for elective LSCS under SA. Gestation >= 36 weeks.

Exclusion criteria

Exclusion criteria: Patient refusal. Patient with Coagulopathies or anticoagulant medication Any systemic disease, hypothyroidism, diabetic neuropathy Severe pre-eclampsia, eclampsia, placenta previa, APH Psychiatric patient History of allergic reaction to study drugs.

Design outcomes

Primary

MeasureTime frame
Incidence and Intensity of shiveringTimepoint: Intraoperative 1hr—

Secondary

MeasureTime frame
Hemodynamic parameters Incidence of complications, including hypotension, bradycardia and sedation due to study drugs. Timepoint: 1hr—

Countries

India

Contacts

Public ContactPramilakumari

Rabindranath tagor govt. medical college

dr.rgehlot.2010@gmail.com9468694902

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026